CD274 and neoplasm: Overall response rates (ORR) which include a complete response (CR) and partial response (PR) were 36.7% and 20% for patients with a PD-L1 tumor proportion score (TPS) of 50% or greater and 1–49%, respectively, in line with previous studies51,52.